A QoE looks at revenue. Legal diligence looks at contracts. The claims on the listing sit in neither.
Tests the numbers. Never reads the listing that produces them.
Reads the agreements. The claims on the page sit outside them.
Listings, site, ads and labels, ruled against 109 published standards and signed.
Plaintiffs read the same copy your buyers do, and quote it back as the exhibit.
Every public claim the target makes, ruled and rated by severity, with every fix written and sized by what it takes. A redacted sample report is public, and the diligence exhibit format is available before you commit.
A claims exhibit dated after closing is not diligence, it is an explanation. It is worth having because it exists before the price is agreed, the only window in which a finding can still move the price.
If a marketplace or regulator acts on the target’s copy after close, your side gets asked what was done to check it, and by whom. A dated exhibit signed by a licensed pharmacist answers that. A warranty from the seller does not.
Fixed once scope is agreed, whether the target comes back clean or badly exposed. Nobody here is paid more for a worse result, which is the first thing a seller’s counsel asks about whoever produced the exhibit.
Amazon listings (backend keywords included), DTC site, ad library creative, labels and inserts.
Earlier versions of a listing where our database captured them, cross-referenced against published FDA warning letters and FTC actions.
By the fix it needs (a copy edit, a label reprint or a rename), and marked as a takedown trigger or fix-then-pass.
The target’s full SKU set scored against the best-selling set in its categories.
Each product’s label record with the NIH, and its Health Canada licence where one is supplied. Pharmacist-signed, statute-cited, a standalone exhibit your deal team can forward.
What this exhibit does not do is promise that no platform or regulator ever acts on the target’s copy. Nobody can promise that. It records which claims were reviewed, against which published standards, on what date, and by whom. That is what a diligence file is for.
The same review, run by whoever gets there first.
A per-target report before the LOI firms up, or a portfolio sweep across existing holdings. Your dashboard shows the portfolio product by product, each ranked against every top-selling listing in its category with every fix counted by what it takes, for your IC to weigh against the price.
A clean claims file before the data room opens: the review a buy-side team would run, run first, with every finding rewritten to the rules before the file goes out. A brand that passes also qualifies for the verified register, a third-party reference an acquirer can check from the data room.
Brokers and bankers: we work referral terms, ask.
Send the target category and SKU count. Email audit@claimsverified.org with the subject “Diligence”. We reply within one business day.
Review of marketing language only, not product testing, formulation, facility compliance, financial or legal advice. Findings are our opinion under the published Claims Verified standards.
Supplement claims review. Every public claim ruled against 109 published standards, rewritten to the rules and signed by a licensed pharmacist.